Summary

The global automated microscopy market was valued at $7.1 billion in 2022, and is projected to reach $13 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.
Automated microscopes have become invaluable tools in the healthcare sector, revolutionizing the way medical professionals conduct diagnostic and research activities. Automated microscope combines the power of traditional microscopy with advanced automation and digital imaging technologies. Automated microscopes streamline the imaging process by automatically focusing, scanning, and capturing high-resolution images of biological specimens, including tissue samples, blood cells, and microorganisms. Automation not only enhances efficiency and reduces the risk of human error but also allows for high-throughput analysis, making them essential for tasks such as cancer screening, blood cell counting, and microbiological research.

The major key factor that contributes toward the market growth includes surge in adoption of automated microscope owing to its high precision, technological advancement in automated microscopy technology. The healthcare industry has witnessed a remarkable surge in the adoption of automated microscopes, driven primarily by their unparalleled precision and numerous advantages. Automated microscopes are equipped with advanced imaging and analytical capabilities that offer high levels of precision and consistency in a wide range of medical applications, from diagnosing diseases to conducting research. Automated microscopes not only enhance the accuracy of diagnoses but also significantly reduce the margin of error, making them invaluable tools for healthcare professionals. Automated microscopes are capable of handling large volumes of samples efficiently and can automatically scan, capture, and analyze microscopic images, reducing the need for manual intervention. This not only saves time but also enhances productivity, making healthcare operations more cost-effective. Some automated microscopes used for medical diagnosis are BioTek Lionheart LX Automated Microscope IVD (Agilent Technologies, Inc.) and BioTek Lionheart FX Automated Microscope.
Technological advancements such as integration of imaging software in the automated microscopes have emerged as a major driver for the automated microscopy market. This technological advancement has revolutionized the way healthcare professionals and researchers analyze cellular and molecular structures, thereby facilitating more accurate diagnoses and cutting-edge research. The incorporation of sophisticated imaging software allows for the automation of complex microscopy processes, such as image acquisition, analysis, and data interpretation. This automation not only enhances the efficiency of healthcare laboratories but also reduces the risk of human error, ultimately improving the reliability and consistency of results. For instance, in 2022, the National Library of Medicine conducted a study to evaluate the GIANI (General Image Analysis of Nuclei-based Images) image analysis software for automated analysis for microscopes. The study anticipated the GIANI will be a useful tool for researchers in various biomedical fields. Thus, the technological advancement in automated microscopy is expected to drive the growth of the market.

However, high cost of automated microscopes is the major restraint for the market growth. In addition, integration of artificial intelligence in the automated microscopy presents major growth opportunity for the market growth in the future.
The global automated microscopy market is segmented on the basis of product, application, end use, and region. By product, the market is classified into optical microscope, electron microscope and scanning probe microscope. By application, the market is categorized into medical diagnosis, life science research and drug discovery and development. Based on end user, the market is segmented into diagnostic laboratories, research laboratories and pharmaceutical industry. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

North America accounted for a majority of the global automated microscopy market share in 2022 and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic disorder, strong presence of key players, and high number of tattoo removal procedures. However, Asia-Pacific is anticipated to witness fastest growth during the forecast period, owing to increase in prevalence of ophthalmic disorders, and rise in number of hospitals & clinics.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the automated microscopy market analysis from 2022 to 2032 to identify the prevailing automated microscopy market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the automated microscopy market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global automated microscopy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● New Product Development/ Product Matrix of Key Players
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Criss-cross segment analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
● SWOT Analysis
Key Market Segments
By Product type
● Optical microscope
● Electron microscope
● Scanning probe microscope
By Application
● Medical diagnosis
● Life science research
● Drug discovery and Pharmaceutical
By End User
● Diagnostic laboratories
● Research Facilities
● Pharmaceutical industry
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ Etaluma, Inc.
○ Bruker Corporation
○ Horiba Scientific
○ Carl Zeiss AG
○ Olympus Corporation
○ Agilent Technologies, Inc.
○ Thermo Fisher Scientific
○ Nikon Corporation.
○ Hitachi High-Technologies
○ Danaher Corporation

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in adoption of the automated microscope for the research and development activities.
3.4.1.2. Growth in demand for automated microscopes in disease diagnosis.
3.4.2. Restraints
3.4.2.1. High cost of automated microscope.
3.4.3. Opportunities
3.4.3.1. Integration of artificial intelligence in automated microscope.
CHAPTER 4: AUTOMATED MICROSCOPY MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Optical microscope
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Electron microscope
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Scanning probe microscope
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: AUTOMATED MICROSCOPY MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Medical diagnosis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Life science research
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Drug discovery and Pharmaceutical
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: AUTOMATED MICROSCOPY MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic laboratories
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Research Facilities
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Pharmaceutical industry
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: AUTOMATED MICROSCOPY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Product type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Product type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Agilent Technologies, Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Bruker Corporation
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Carl Zeiss AG
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Olympus Corporation
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Thermo Fisher Scientific
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Horiba Scientific
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Nikon Corporation.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Etaluma, Inc.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Hitachi High-Technologies
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Danaher Corporation
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance